Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tecogen (TGEN) EBITDA (2016 - 2025)

Tecogen (TGEN) has disclosed EBITDA for 14 consecutive years, with -$2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA fell 140.57% year-over-year to -$2.1 million, compared with a TTM value of -$5.2 million through Sep 2025, down 0.6%, and an annual FY2024 reading of -$4.5 million, down 2.73% over the prior year.
  • EBITDA was -$2.1 million for Q3 2025 at Tecogen, down from -$1.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $139644.0 in Q4 2021 and bottomed at -$2.1 million in Q3 2025.
  • Average EBITDA over 5 years is -$874881.3, with a median of -$873224.0 recorded in 2024.
  • The sharpest move saw EBITDA soared 158.26% in 2022, then crashed 1890.27% in 2023.
  • Year by year, EBITDA stood at $139644.0 in 2021, then plummeted by 1101.47% to -$1.4 million in 2022, then decreased by 29.81% to -$1.8 million in 2023, then surged by 37.37% to -$1.1 million in 2024, then tumbled by 84.76% to -$2.1 million in 2025.
  • Business Quant data shows EBITDA for TGEN at -$2.1 million in Q3 2025, -$1.4 million in Q2 2025, and -$594244.0 in Q1 2025.